Foulongne V - Search Results

1

Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment.

Hirt D, Bardin C, Diagbouga S, Nacro B, Hien H, Zoure E, Rouet F, Ouiminga A, Urien S, Foulongne V, Van De Perre P, Tréluyer JM, Msellati P. Hirt D, et al. Among authors: foulongne v. Antimicrob Agents Chemother. 2009 Oct;53(10):4399-406. doi: 10.1128/AAC.01187-08. Epub 2009 Jul 6. Antimicrob Agents Chemother. 2009. PMID: 19581461 Free PMC article. Clinical Trial.

2

Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial.

Nacro B, Zoure E, Hien H, Tamboura H, Rouet F, Ouiminga A, Drabo A, Yameogo S, Hien A, Peyriere H, Mathieu O, Hirt D, Treluyer JM, Nicolas J, Foulongne V, Segondy M, van de Perre P, Diagbouga S, Msellati P. Nacro B, et al. Among authors: foulongne v. Bull World Health Organ. 2011 Jun 1;89(6):451-8. doi: 10.2471/BLT.10.081646. Epub 2011 Apr 6. Bull World Health Organ. 2011. PMID: 21673861 Free PMC article. Clinical Trial.

3

Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname.

Barro M, Some J, Foulongne V, Diasso Y, Zouré E, Hien H, François R, Michel S, Drabo A, Tamboura H, Ouiminga A, Diagbouga S, Hien A, Yaméogo S, Van De Perre P, Nacro B, Msellati P. Barro M, et al. Among authors: foulongne v. J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S44-9. doi: 10.1097/QAI.0b013e31821fd64f. J Acquir Immune Defic Syndr. 2011. PMID: 21857286 Clinical Trial.

4

Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study.

Rouet F, Foulongne V, Viljoen J, Steegen K, Becquart P, Valéa D, Danaviah S, Segondy M, Verhofstede C, Van de Perre P; WHO/ANRS 1289 Kesho Bora Study Group. Rouet F, et al. Among authors: foulongne v. J Virol Methods. 2010 Feb;163(2):253-7. doi: 10.1016/j.jviromet.2009.10.005. Epub 2009 Oct 27. J Virol Methods. 2010. PMID: 19837114

5

CD4+ T cells spontaneously producing human immunodeficiency virus type I in breast milk from women with or without antiretroviral drugs.

Valea D, Tuaillon E, Al Tabaa Y, Rouet F, Rubbo PA, Meda N, Foulongne V, Bollore K, Nagot N, Van de Perre P, Vendrell JP. Valea D, et al. Among authors: foulongne v. Retrovirology. 2011 May 13;8:34. doi: 10.1186/1742-4690-8-34. Retrovirology. 2011. PMID: 21569457 Free PMC article.

6

Early infant feeding patterns and HIV-free survival: findings from the Kesho-Bora trial (Burkina Faso, Kenya, South Africa).

Cournil A, Van de Perre P, Cames C, de Vincenzi I, Read JS, Luchters S, Meda N, Naidu K, Newell ML, Bork K; Kesho Bora Study Group. Cournil A, et al. Pediatr Infect Dis J. 2015 Feb;34(2):168-74. doi: 10.1097/INF.0000000000000512. Pediatr Infect Dis J. 2015. PMID: 25741969 Clinical Trial.

7

Near-point-of-care assay with a visual readout for detection of HIV-1 drug resistance mutations: A proof-of-concept study.

Gomez-Martinez J, Foulongne V, Laureillard D, Nagot N, Montès B, Cantaloube JF, Van de Perre P, Fournier-Wirth C, Molès JP, Brès JC. Gomez-Martinez J, et al. Among authors: foulongne v. Talanta. 2021 Aug 15;231:122378. doi: 10.1016/j.talanta.2021.122378. Epub 2021 Mar 30. Talanta. 2021. PMID: 33965042

8

Herpes Simplex Virus Type-2 Cervicovaginal Shedding Among Women Living With HIV-1 and Receiving Antiretroviral Therapy in Burkina Faso: An 8-Year Longitudinal Study.

Low AJ, Nagot N, Weiss HA, Konate I, Kania D, Segondy M, Meda N, van de Perre P, Mayaud P; Yerelon Study Group. Low AJ, et al. J Infect Dis. 2016 Mar 1;213(5):731-7. doi: 10.1093/infdis/jiv495. Epub 2015 Oct 15. J Infect Dis. 2016. PMID: 26475931 Free PMC article.

9

Viral load and genomic integration of HPV 16 in cervical samples from HIV-1-infected and uninfected women in Burkina Faso.

Rousseau MN, Costes V, Konate I, Nagot N, Foulongne V, Ouedraogo A, Van de Perre P, Mayaud P, Segondy M; Yerelon Study Group. Rousseau MN, et al. Among authors: foulongne v. J Med Virol. 2007 Jun;79(6):766-70. doi: 10.1002/jmv.20888. J Med Virol. 2007. PMID: 17457905

10

Viral load and physical status of human papillomavirus (HPV) 18 in cervical samples from female sex workers infected with HPV 18 in Burkina Faso.

Damay A, Didelot-Rousseau MN, Costes V, Konate I, Ouedraogo A, Nagot N, Foulongne V, Van de Perre P, Mayaud P, Segondy M. Damay A, et al. Among authors: foulongne v. J Med Virol. 2009 Oct;81(10):1786-91. doi: 10.1002/jmv.21554. J Med Virol. 2009. PMID: 19697418

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters